Feb 10, 2026
BeyondSpring to Participate at the 12th Annual Immuno-Oncology 360◦ Conference
Dec 12, 2025
BeyondSpring Announces ESMO Asia Presentation on Plinabulin + Docetaxel Improving…
Dec 11, 2025
BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing…
Jun 27, 2025
Med (Cell Press) 2025
Sep 19, 2024
Lancet Respiratory Medicine 2024
Sep 14, 2023
JNCCN 2023
Nov 16, 2025
PP01.45: Phase 3 Study of Plinabulin/Docetaxel vs. Docetaxel in 2L/3L…
Oct 23, 2025
Phase 2 study of pembrolizumab (Pemb) plus plinabulin (Plin) and…
Sep 10, 2025
Immune Activation with Plinabulin Enhances Anti-tumor Response Combining Radiation with…
We'd love to hear from you!
general@beyondspringpharma.com
+1 646 305-6387
100 Campus Dr, Florham Park, NJ 07932.
First name*
Last Name*
Phone
Company
Email*
Please select your institution type Select Academia Biotech CRO Government Human Hospital or Hospital Medical Device Pharmaceutical Private research Organizer Vendor Vet Practice/Vet Hospital Zoo Other Unknown
Leave a message*
I agree to Privacy Policy.
Δ